Schonfeld Strategic Advisors LLC Arcellx, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$49.74 - $66.98 $1.48 Million - $1.99 Million	-29,776 Reduced 56.26%	23,148 $1.28 Million
Q1 2024 May 15, 2024	BUY	$51.85 - $73.49 $643,665 - $912,304	12,414 Added 30.64%	52,924 $3.68 Million
Q4 2023 Feb 14, 2024	SELL	$31.75 - $57.99 $503,142 - $918,967	-15,847 Reduced 28.12%	40,510 $2.25 Million
Q3 2023 Nov 14, 2023	BUY	$31.51 - $37.4 $223,689 - $265,502	7,099 Added 14.41%	56,357 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$27.49 - $46.9 $375,568 - $640,747	13,662 Added 38.38%	49,258 $1.56 Million
Q1 2023 May 15, 2023	BUY	$26.92 - $33.94 $573,234 - $722,718	21,294 Added 148.89%	35,596 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$17.18 - $33.0 $64,785 - $124,443	3,771 Added 35.81%	14,302 $443,000
Q3 2022 Nov 14, 2022	BUY	$16.67 - $22.04 $175,551 - $232,103	10,531 New	10,531 $197,000

204

44.1M

2.23M

907K

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $2.99B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.